For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $43.80 in the prior trading day, Protagonist Therapeutics Inc (NASDAQ: PTGX) closed at $43.26, down -1.23%. In other words, the price has decreased by -$1.23 from its previous closing price. On the day, 0.55 million shares were traded. PTGX stock price reached its highest trading level at $43.825 during the session, while it also had its lowest trading level at $42.52.
Ratios:
Our goal is to gain a better understanding of PTGX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.96. For the most recent quarter (mrq), Quick Ratio is recorded 10.70 and its Current Ratio is at 10.70. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on November 05, 2024, initiated with a Outperform rating and assigned the stock a target price of $58.
On September 24, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $65.
On September 09, 2024, Truist started tracking the stock assigning a Buy rating and target price of $60.Truist initiated its Buy rating on September 09, 2024, with a $60 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 27 ’24 when MOLINA ARTURO MD sold 26,000 shares for $44.70 per share. The transaction valued at 1,162,280 led to the insider holds 46,444 shares of the business.
MOLINA ARTURO MD sold 5,529 shares of PTGX for $252,122 on Nov 26 ’24. The Chief Medical Officer now owns 46,444 shares after completing the transaction at $45.60 per share. On Nov 25 ’24, another insider, Gupta Suneel, who serves as the Chief Development Officer of the company, sold 103,437 shares for $46.04 each. As a result, the insider received 4,762,239 and left with 256,174 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTGX now has a Market Capitalization of 2578209280 and an Enterprise Value of 2120389248. As of this moment, Protagonist’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.76 while its Price-to-Book (P/B) ratio in mrq is 4.84. Its current Enterprise Value per Revenue stands at 6.549 whereas that against EBITDA is 14.13.
Stock Price History:
Over the past 52 weeks, PTGX has reached a high of $48.89, while it has fallen to a 52-week low of $17.70. The 50-Day Moving Average of the stock is -4.11%, while the 200-Day Moving Average is calculated to be 19.14%.
Shares Statistics:
The stock has traded on average 683.64K shares per day over the past 3-months and 1083230 shares per day over the last 10 days, according to various share statistics. A total of 59.52M shares are outstanding, with a floating share count of 56.30M. Insiders hold about 5.54% of the company’s shares, while institutions hold 100.40% stake in the company. Shares short for PTGX as of 1731628800 were 3301009 with a Short Ratio of 4.83, compared to 1728950400 on 3001498. Therefore, it implies a Short% of Shares Outstanding of 3301009 and a Short% of Float of 5.609999999999999.
